Stati Uniti - inglese - NLM (National Library of Medicine)

burel pharmaceuticals, llc - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - i. stable angina nicardipine hydrochloride capsules are indicated for the management of patients with chronic stable angina (effort-associated angina). nicardipine hydrochloride capsules may be used alone or in combination with beta-blockers. ii. hypertension nicardipine hydrochloride capsules are indicated for the treatment of hypertension. nicardipine hydrochloride capsules may be used alone or in combination with other antihypertensive drugs. in administering nicardipine hydrochloride it is important to be aware of the relatively large peak to trough differences in blood pressure effect (see dosage and administration ). nicardipine hydrochloride capsules are contraindicated in patients with hypersensitivity to the drug. because part of the effect of nicardipine hydrochloride capsules are secondary to reduced afterload, the drug is also contraindicated in patients with advanced aortic stenosis. reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance.

Stati Uniti - inglese - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - 1.1 hypertension cardene® i.v. (nicardipine hydrochloride) premixed injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. for prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see dosage and administration ( 2-2.1)]. 4.1 advanced aortic stenosis cardene i.v. premixed injection is contraindicated in patients with advanced aortic stenosis because part of the effect of cardene i.v. premixed injection is secondary to reduced afterload. reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance. 8.1 pregnancy pregnancy category c there are no adequate and well-controlled studies of nicardipine use in pregnant women. however, limited human data in pregnant women with preeclampsia or pre-term labor are available. in animal studies, no embryotoxicity occurred in rats with oral doses 8 times the maximum recommended human dose (mrhd)

Stati Uniti - inglese - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - 1.1 hypertension nicardipine hydrochloride injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable. for prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see dosage and administration (2.6)]. 4.1 advanced aortic stenosis do not use nicardipine in patients with advanced aortic stenosis because of the afterload reduction effect of nicardipine. reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance. 8.1 pregnancy pregnancy category c. there are no adequate and well-controlled studies of nicardipine use in pregnant women. there are limited human data in pregnant women with pre-eclampsia and preterm labor. in animal reproduction and developmental toxicity studies, evidence of fetal harm was observed. therefore use nicardipine during pregnancy only if the potential benefit justifies the potential risk to the fetus. in reproduction stud

Stati Uniti - inglese - NLM (National Library of Medicine)

micro labs limited - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable. for prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see dosage and administration (2.6)] . do not use nicardipine in patients with advanced aortic stenosis because of the afterload reduction effect of nicardipine. reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance. there are no adequate and well-controlled studies of nicardipine use in pregnant women. there are limited human data in pregnant women with pre-eclampsia and preterm labor. in animal reproduction and developmental toxicity studies, evidence of fetal harm was observed. therefore use nicardipine during pregnancy only if the potential benefit justifies the potential risk to the fetus. in reproduction studies conducted in rats and rabbits, increased embryolethality occurred

Stati Uniti - inglese - NLM (National Library of Medicine)

avera mckennan hospital - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 30 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

mylan institutional llc - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 2.5 mg in 1 ml

Stati Uniti - inglese - NLM (National Library of Medicine)

avkare, inc. - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 20 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

sun pharma global inc. - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 2.5 mg in 1 ml

Stati Uniti - inglese - NLM (National Library of Medicine)

chiesi usa, inc. - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 0.1 mg in 1 ml - cardene® i.v. (nicardipine hydrochloride) premixed injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable.  for prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see dosage and administration (2.1)] . cardene i.v. premixed injection is contraindicated in patients with advanced aortic stenosis because part of the effect of cardene i.v. premixed injection is secondary to reduced afterload.  reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance. pregnancy category c there are no adequate and well-controlled studies of nicardipine use in pregnant women.  however,  limited human data in pregnant women with preeclampsia or pre-term labor are available.  in animal studies, no embryotoxicity occurred in rats with oral doses 8 times the maximum recommended human dose (mrhd) based on body surface area (mg/m2 ), but did occur in rabbits

Stati Uniti - inglese - NLM (National Library of Medicine)

carilion materials management - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride capsules are indicated for the management of patients with chronic stable angina (effort-associated angina). they may be used alone or in combination with beta-blockers. nicardipine hydrochloride capsules are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive drugs. in administering nicardipine hydrochloride it is important to be aware of the relatively large peak to trough differences in blood pressure effect. (see dosage and administration.) nicardipine hydrochloride is contraindicated in patients with hypersensitivity to the drug. because part of the effect of nicardipine is secondary to reduced afterload, the drug is also contraindicated in patients with advanced aortic stenosis. reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance.